Home » Topics » BioWorld Science

BioWorld Science
RSS

Discovery and preclinical data presented for VNRX-9945

July 2, 2021

Ildong announces initiation of phase I study of IDG-16177 in Germany

July 2, 2021

LG Chem reports data from phase II CLUE study of LC-350189 in chronic gout

July 2, 2021

ALG-010133: a STOPS for chronic hepatitis B treatment

July 2, 2021

Exome study identifies new genetic influences on weight

July 2, 2021

Aileron initiates phase Ib study of ALRN-6924 in advanced NSCLC

July 2, 2021

FDA provides notice to proceed with phase I study of HDT-301 RNA COVID-19 vaccine

July 2, 2021

Topline phase II data for VAL-083 in patients with recurrent GBM

July 2, 2021

I-Mab provides updates for its 4-1BB bispecific antibody portfolio

July 2, 2021

PRO-C18L may predict response to liver fibrosis treatment

July 2, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...